Commonwealth Retirement Investments’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$295K Hold
1,931
0.09% 107
2025
Q4
$266K Hold
1,931
0.09% 113
2025
Q3
$248K Hold
1,931
0.08% 111
2025
Q2
$234K Hold
1,931
0.09% 108
2025
Q1
$215K Buy
+1,931
New +$206K 0.09% 94
2024
Q4
Sell
-1,931
Closed -$222K 102
2024
Q3
$222K Hold
1,931
0.09% 88
2024
Q2
$206K Buy
+1,931
New +$194K 0.09% 88

Other funds holding NVS

Commonwealth Retirement Investments's NVS Position: Q1 2026 in Review

Commonwealth Retirement Investments held its Novartis (NVS) position steady in Q1 2026 at 1,931 shares worth $295K. The position accounts for 0.09% of the portfolio, ranked #107.

Commonwealth Retirement Investments first reported a position in NVS in Q2 2024 and has held it in 7 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Commonwealth Retirement Investments held 1,931 shares of Novartis worth $295K as of Q1 2026.
  • Commonwealth Retirement Investments left its Novartis share count unchanged in Q1 2026.
  • Novartis made up 0.09% of Commonwealth Retirement Investments's portfolio in Q1 2026, its #107 holding.
  • Commonwealth Retirement Investments first reported a position in Novartis in Q2 2024 and has held it in 7 quarters since.
  • 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Commonwealth Retirement Investments's 13F filing for Q1 2026, filed 11 May 2026.